PRTA Q2 2025 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-96.7% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$85M-1914.4% margin

Net Income

-$126M-2845.4% margin

EPS (Diluted)

$-2.34

QoQ Revenue Growth

+56.3%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$399M

Total Liabilities

$75M

Stockholders' Equity

$324M

Cash & Equivalents

$371M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$132M	-96.7%
Gross Profit	$4M	$132M	-96.7%
Operating Income	-$85M	$58M	-244.9%
Net Income	-$126M	$67M	-288.0%

Revenue Segments

Collaboration

$4M100%